L-Arginine-13C6 (hydrochloride)
(Synonyms: L-(+)-Arginine-13C6) 目录号 : GC52310An internal standard for the quantification of L-arginine
Cas No.:201740-91-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
L-Arginine-13C6 is intended for use as an internal standard for the quantification of L-arginine by GC- or LC-MS. L-Arginine is an amino acid and a precursor of nitric oxide (NO).1 L-Arginine is a substrate for NO synthase that is oxidized to form NO and L-citrulline. It enhances NO release induced by bradykinin or A23187 in porcine aortic endothelial cells.2 L-Arginine (30 and 300 mg/kg, i.v.) induces dilation of pial arterioles and increases cerebral blood flow in normotensive and spontaneously hypertensive rats.3 It also reduces infarct size by 35 and 28% in normotensive and spontaneously hypertensive rats, respectively, following middle cerebral artery occlusion.
1.Stuehr, D.J.Enzymes of the L-arginine to nitric oxide pathwayJ. Nutr.134(10 Suppl)2748S-2751S(2004) 2.Palmer, R.M.J., Ashton, D.S., and Moncada, S.Vascular endothelial cells synthesize nitric oxide from L-arginineNature333(6174)664-666(1988) 3.Morikawa, E., Moskowitz, M.A., Huang, Z., et al.L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the ratStroke25(2)429-435(1994)
Cas No. | 201740-91-2 | SDF | Download SDF |
别名 | L-(+)-Arginine-13C6 | ||
Canonical SMILES | N=[13C](N)N[13CH2][13CH2][13CH2][13C@H](N)[13C](O)=O.Cl | ||
分子式 | [13C]6H14N4O2 ? HCl | 分子量 | 216.6 |
溶解度 | H2O : 250 mg/mL (1154.09 mM; Need ultrasonic) | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 4.6168 mL | 23.084 mL | 46.1681 mL |
5 mM | 0.9234 mL | 4.6168 mL | 9.2336 mL |
10 mM | 0.4617 mL | 2.3084 mL | 4.6168 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。